Ipsen Material Announcements

Financial Results
Corporate News
Financial Calendar
Investor Events
Reports and Accounts

Key highlights

Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio

– 02 March 2023 – 1 mins read

02 March 2023 – 1 mins read

Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio

PARIS, FRANCE, 3 March 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced it has completed the acquisition of Albireo Pharma, Inc., a leading innovator in bile-acid modulators to treat rare liver conditions. The acquisition enriches Ipsen’s Rare Disease portfolio, with…